Chade DC - Search Results

1

Oncological outcomes after radical cystectomy for bladder cancer: open versus minimally invasive approaches.

Chade DC, Laudone VP, Bochner BH, Parra RO. Chade DC, et al. J Urol. 2010 Mar;183(3):862-69. doi: 10.1016/j.juro.2009.11.019. Epub 2010 Jan 18. J Urol. 2010. PMID: 20083269 Review.

2

Words of wisdom. Re: Pathologic stage T2a and T2b prostate cancer in the recent prostate-specific antigen era: implications for unilateral ablative therapy. Polascik TJ, Mayes JM, Sun L, Madden JF, Moul JW, Mouraviev V.

Godoy G, Chade DC, Shariat SF. Godoy G, et al. Among authors: chade dc. Eur Urol. 2009 Sep;56(3):573-5. doi: 10.1016/j.eururo.2009.06.019. Eur Urol. 2009. PMID: 19824127 No abstract available.

3

Combination of multiple molecular markers can improve prognostication in patients with locally advanced and lymph node positive bladder cancer.

Shariat SF, Chade DC, Karakiewicz PI, Ashfaq R, Isbarn H, Fradet Y, Bastian PJ, Nielsen ME, Capitanio U, Jeldres C, Montorsi F, Lerner SP, Sagalowsky AI, Cote RJ, Lotan Y. Shariat SF, et al. Among authors: chade dc. J Urol. 2010 Jan;183(1):68-75. doi: 10.1016/j.juro.2009.08.115. J Urol. 2010. PMID: 19913255

4

Intravesical therapy for urothelial carcinoma of the urinary bladder: a critical review.

Chade DC, Shariat SF, Dalbagni G. Chade DC, et al. Int Braz J Urol. 2009 Nov-Dec;35(6):640-50; discussion 651. doi: 10.1590/s1677-55382009000600002. Int Braz J Urol. 2009. PMID: 20028569 Free PMC article. Review.

5

Association of angiogenesis related markers with bladder cancer outcomes and other molecular markers.

Shariat SF, Youssef RF, Gupta A, Chade DC, Karakiewicz PI, Isbarn H, Jeldres C, Sagalowsky AI, Ashfaq R, Lotan Y. Shariat SF, et al. Among authors: chade dc. J Urol. 2010 May;183(5):1744-50. doi: 10.1016/j.juro.2010.01.018. Epub 2010 Mar 17. J Urol. 2010. PMID: 20299037

6

Characteristics and outcomes of patients with clinical carcinoma in situ only treated with radical cystectomy: an international study of 243 patients.

Tilki D, Reich O, Svatek RS, Karakiewicz PI, Kassouf W, Novara G, Ficarra V, Chade DC, Fritsche HM, Gerwens N, Izawa JI, Lerner SP, Schoenberg M, Stief CG, Skinner E, Lotan Y, Sagalowsky AI, Shariat SF. Tilki D, et al. Among authors: chade dc. J Urol. 2010 May;183(5):1757-63. doi: 10.1016/j.juro.2010.01.025. Epub 2010 Mar 17. J Urol. 2010. PMID: 20299059

7

Predicting biochemical recurrence-free survival for patients with positive pelvic lymph nodes at radical prostatectomy.

von Bodman C, Godoy G, Chade DC, Cronin A, Tafe LJ, Fine SW, Laudone V, Scardino PT, Eastham JA. von Bodman C, et al. Among authors: chade dc. J Urol. 2010 Jul;184(1):143-8. doi: 10.1016/j.juro.2010.03.039. Epub 2010 May 15. J Urol. 2010. PMID: 20478587 Free PMC article.

8

Clinical outcomes of primary bladder carcinoma in situ in a contemporary series.

Chade DC, Shariat SF, Godoy G, Savage CJ, Cronin AM, Bochner BH, Donat SM, Herr HW, Dalbagni G. Chade DC, et al. J Urol. 2010 Jul;184(1):74-80. doi: 10.1016/j.juro.2010.03.032. J Urol. 2010. PMID: 20546806 Free PMC article.

9

Clinical outcome of primary versus secondary bladder carcinoma in situ.

Chade DC, Shariat SF, Adamy A, Bochner BH, Donat SM, Herr HW, Dalbagni G. Chade DC, et al. J Urol. 2010 Aug;184(2):464-9. doi: 10.1016/j.juro.2010.03.134. Epub 2010 Jun 17. J Urol. 2010. PMID: 20620399 Free PMC article.

10

Update on intravesical agents for non-muscle-invasive bladder cancer.

Shariat SF, Chade DC, Karakiewicz PI, Scherr DS, Dalbagni G. Shariat SF, et al. Among authors: chade dc. Immunotherapy. 2010 May;2(3):381-92. doi: 10.2217/imt.10.1. Immunotherapy. 2010. PMID: 20635902 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46 results

Search Page

Filters